Restore
Recover a function that injury, disease, or development limited.
Hearing · movement · communicationBody upgrades range from glasses and pacemakers to experimental neural interfaces and speculative synthetic senses. This guide maps what exists, what is being tested, what remains difficult, and what is still science fiction.
Separate established restoration from clinical experiments, research prototypes, and speculation.
Find the answer THE SYSTEM / 02The real upgrade is a closed loop joining sensors, software, living tissue, and learning.
Find the answer THE LIMIT / 03Signal reading is not mind transfer, and integration matters more than a dramatic demo.
Find the answerThe same platform can restore a lost function for one person, enhance performance for another, and create a new ability in a future version.
Recover a function that injury, disease, or development limited.
Hearing · movement · communicationDetect risk early, stabilise a system, or prevent loss before it happens.
Sensors · stimulation · preventionMove a capacity beyond a person’s previous or typical baseline.
Strength · focus · resilienceCreate a direct information loop between body, device, and environment.
BCI · adaptive implants · wearablesAdd a capability with no close biological equivalent.
New senses · new embodiment · remote presenceAvailable in established or regulated use.
Used selectively or being tested with people.
Prototype, laboratory, or early-stage work.
Plausible direction, not a demonstrated product.
“Today” describes established or demonstrated capability, not universal availability. Every medical device or therapy has specific indications, risks, and regulatory status.
Cochlear implants translate sound into electrical stimulation of the auditory nerve. Corrective lenses and implanted lenses reshape incoming light. Haptic systems turn information into vibration or pressure.
Higher-fidelity sensory encoding, selective restoration for damaged vision, and feedback that lets a prosthetic hand communicate pressure or contact.
Adding a channel with no natural equivalent—such as translating magnetic direction, distance, or machine state into a learnable sensation.
THE HARD PARTThe brain must learn the signal. More data is not automatically more perception.
Myoelectric prostheses use muscle signals to control powered joints. Exoskeletons support selected rehabilitation and industrial tasks. Functional electrical stimulation can activate muscles in patterned ways.
More natural control, sensory feedback, lighter power systems, osseointegration in suitable patients, and interfaces that adapt to intention over time.
Strength or endurance that meaningfully exceeds ordinary human limits without sacrificing safety, mobility, or autonomy.
THE HARD PARTWeight, heat, battery life, comfort, tissue interface, training, and the complexity of real-world movement.
Deep-brain and spinal-cord stimulation are established for selected conditions. Implanted and non-invasive systems can record limited neural signals; small clinical studies have enabled cursor, text, or device control.
Higher-bandwidth communication, speech decoding, adaptive stimulation, and closed-loop systems that respond to a person’s changing neural state.
Effortless thought-to-device control, shared sensory spaces, or memory assistance that works broadly and safely.
THE HARD PARTSignals drift, brains differ, surgery carries risk, bandwidth is limited, and neural data is exceptionally intimate.
Pacemakers, implanted defibrillators, artificial joints, dialysis, ventricular-assist devices, and transplants already replace or support essential functions.
Longer-lived devices, better biocompatibility, gene-edited donor organs, tissue patches, and implants that continuously sense and adjust.
Personalised replacement organs grown with a patient’s own cells and integrated without lifelong immune suppression.
THE HARD PARTBlood supply, immune response, clotting, infection, mechanical wear, manufacturing, and long-term monitoring.
Continuous glucose monitors and automated insulin-delivery systems show the core upgrade pattern: sense a variable, calculate a response, act, then measure again.
More biomarkers, smaller sensors, longer wear, less calibration, and systems that predict a change before it becomes dangerous.
A body-wide operating layer that coordinates multiple organs and interventions in real time.
THE HARD PARTBiology is noisy, sensors foul or drift, and an automated decision can become dangerous when context is missing.
Approved gene and engineered-cell therapies can address selected diseases. These are precise medical interventions for defined indications—not general-purpose character editors.
Safer delivery, control over when an edit acts, more treatable tissues, lower cost, and therapies that can be adjusted or stopped.
Complex enhancement of traits such as cognition, strength, or ageing resistance across healthy people.
THE HARD PARTMost traits involve many genes and environments. Delivery, unintended effects, immune response, and heritability make ‘editing the code’ a misleadingly simple metaphor.
Some tissue and cell therapies are established for specific uses. Organoids and engineered tissues are powerful research tools, while broad whole-organ replacement remains difficult.
Repairing cartilage, nerves, muscle, skin, and organ damage with scaffolds, cells, signals, and better control of inflammation.
Routine regeneration that restores an adult body with the speed and completeness seen in a few other animals.
THE HARD PARTGrowth must stop at the right time, connect to nerves and blood vessels, and avoid scarring, rejection, or cancer.
Vaccination, sanitation, cardiovascular care, cancer screening, exercise, and risk reduction already extend healthy life. No intervention has been shown to make humans biologically immortal or reliably reverse whole-body ageing.
Targeting mechanisms associated with age-related decline while proving that benefits outweigh long-term risks in people.
Repeated maintenance that keeps multiple tissues functionally younger for much longer than today’s normal lifespan.
THE HARD PARTAgeing is a network of interacting processes, and altering one can trade one risk for another.
A passive device performs one fixed job. A closed-loop system measures the body, interprets the signal, responds, and learns whether the response worked.
Capture muscle, neural, chemical, electrical, or movement signals.
Separate intention or state from noise and changing context.
Choose a bounded response under safety and permission rules.
Move, stimulate, dose, display, or translate the information.
Measure the result and adjust as the person and signal change.
Example: a sensory prosthesis. A microphone or sensor captures information, a processor converts it into a coded pattern, an interface stimulates living tissue, and the brain learns how that pattern relates to the world. The device and nervous system become one functional circuit.
There is no automatically “best” interface. The least invasive layer that can do the job often has the strongest safety and maintenance case.
Phones, glasses, controllers, mobility aids, and tools extend capability without becoming attached.
Watches, patches, exoskeletons, smart textiles, and headsets maintain contact and gather continuous data.
Electrodes, pumps, stimulators, prosthetic anchors, and sensors communicate more directly with tissue.
Engineered cells, gene therapies, and regenerative interventions make the change through living material.
Performance is only one measure. A device can work brilliantly and still reduce autonomy if the person cannot control, repair, understand, or leave it.
You decide whether the system is installed, active, altered, shared, or removed. Consent must remain meaningful after installation.
Signals from the body should not become advertising profiles, employment filters, or surveillance data by default.
Connected systems need authentication, update integrity, offline behaviour, and a failure mode that does not abandon the user.
A person should not lose a body function because a company closes, ends support, changes a subscription, or withholds parts.
Removal, replacement, data export, and long-term clinical support should be designed before the first installation.
Users deserve clear evidence, known uncertainty, side effects, expected lifespan, and honest boundaries around what the system cannot do.
Go deeper on gene therapy, engineered cells, regeneration, and the line between treatment and enhancement.
Open biotech guideExplore autonomy, fairness, identity, social pressure, and what “better” is allowed to mean.
Open transhumanism guideThese links lead to public institutions and primary guidance—not product marketing.